2021
DOI: 10.1055/s-0041-1729437
|View full text |Cite
|
Sign up to set email alerts
|

Chimeric Antigen Receptor T-Cell Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…The work of Busch and Fehleisen in the nineteenth century provides insights into the impact of discovery-based research in the immune system's role in combating neoplastic diseases (Rasheed & Koyyala, 2021). At the time, they were independently investigating ways to culture Streptococcus pyogenes, a pathogen with a long history as the causative agent of erysipelas -an infection that has rapid-onset, surface-level skin infection often affects elderly and immunocompromised individuals, newborns and young children, typically following bacterial entry through a breach in the skin (Celestin et al, 2007).…”
Section: Early Days Of Immunotherapymentioning
confidence: 99%
See 1 more Smart Citation
“…The work of Busch and Fehleisen in the nineteenth century provides insights into the impact of discovery-based research in the immune system's role in combating neoplastic diseases (Rasheed & Koyyala, 2021). At the time, they were independently investigating ways to culture Streptococcus pyogenes, a pathogen with a long history as the causative agent of erysipelas -an infection that has rapid-onset, surface-level skin infection often affects elderly and immunocompromised individuals, newborns and young children, typically following bacterial entry through a breach in the skin (Celestin et al, 2007).…”
Section: Early Days Of Immunotherapymentioning
confidence: 99%
“…The curiosity-driven pursuit of advancing immunotherapies formed the foundation of scientific progress, leading researchers to unexpected findings and novel insights (Rasheed & Koyyala, 2021). The evolution of studying T cell biology in the context of cancer treatment highlights the critical need for sustained funding in this realm.…”
Section: Introductionmentioning
confidence: 99%